BAEP & Brainstem Auditory Pathways

Brainstem auditory evoked potentials (BAEPs, also called ABRs — auditory brainstem responses) record the electrical response of the auditory pathway from the cochlea through the brainstem in response to brief acoustic clicks. The stereotyped 7-wave pattern reflects sequential activation of the cochlear nerve, cochlear nucleus, superior olivary complex, lateral lemniscus, and inferior colliculus — each generator producing a recognizable peak. BAEPs are particularly valuable for assessing brainstem integrity in coma, evaluating acoustic neuromas, detecting subclinical brainstem disease in MS, hearing screening in infants, and intraoperative monitoring. This page covers the technique, normal waves, abnormal patterns, and clinical applications.

The BAEP Waveform

Stimulus

  • Brief broadband click (0.1 ms duration).
  • Intensity: 60–90 dB above hearing threshold (typically 75 dB nHL).
  • Repetition rate: 10–20 Hz (slower if neuropathy suspected).
  • Headphones with adequate noise attenuation.
  • Monaural stimulation (one ear at a time).
  • Masking white noise to non-stimulated ear (prevents bone-conducted response).

Recording

  • Active electrode (G1): vertex (Cz).
  • Reference (G2): ipsilateral ear or mastoid (A1 or A2).
  • Ground: forehead (Fpz).
  • Filters: 100 Hz low-frequency, 3 kHz high-frequency.
  • Time base: 1 ms/div, total epoch 10 ms.
  • Averaging: 2000–4000 stimuli (BAEP is very small).

Normal BAEP Waves

Wave Latency (ms, approximate) Generator
I 1.5 Cochlear nerve (distal portion)
II 2.5 Cochlear nucleus and proximal cochlear nerve
III 3.7 Superior olivary complex (pons)
IV 4.7 Lateral lemniscus
V 5.6 Inferior colliculus (most prominent)
VI ~7 Medial geniculate body
VII ~9 Auditory radiations to cortex

Waves I, III, and V are most clinically important. Waves VI and VII are less reliable.

Interpeak Intervals

  • I–III: ~2 ms (cochlear nerve to pons).
  • III–V: ~2 ms (pons to mesencephalon).
  • I–V: ~4 ms (overall conduction).
  • These intervals are independent of peripheral hearing — only affected by brainstem pathology.

Normal Values (Approximate)

  • Wave I: ≤1.7 ms.
  • Wave III: ≤4.0 ms.
  • Wave V: ≤6.0 ms.
  • I–III interpeak: ≤2.3 ms.
  • III–V interpeak: ≤2.3 ms.
  • I–V interpeak: ≤4.4 ms.
  • Interaural difference (between ears): <0.3 ms for V and interpeak intervals.

Abnormal BAEP Patterns

Prolonged Wave I

  • Indicates peripheral hearing loss or cochlear nerve disease.
  • Not a brainstem finding.

Prolonged I–III Interval

  • Conduction delay in cochlear nerve or low pontine pathway.
  • Acoustic neuroma classically.

Prolonged III–V Interval

  • Conduction delay in mid-pontine to mesencephalic pathway.
  • Higher brainstem lesion.

Prolonged I–V Interval

  • Overall conduction delay through brainstem.
  • Non-specific localization.

Absent Waves

  • Wave I absent: peripheral hearing loss, cochlear nerve damage.
  • Wave III absent: low pontine lesion.
  • Wave V absent: high pontine/mesencephalic lesion or severe brainstem injury.
  • All waves absent: severe brainstem injury or brain death (in appropriate context).

Reduced V/I Amplitude Ratio

  • Normally wave V amplitude ≥ wave I.
  • Reduced ratio: conduction problem at higher levels.

Clinical Applications

Acoustic Neuroma (Vestibular Schwannoma)

  • Most common indication for BAEP historically.
  • Classic finding: prolonged I–III interval on the side of the tumor (compression of cochlear nerve in the cerebellopontine angle).
  • Sensitivity 90%+ for tumors >1 cm.
  • MRI with contrast has largely replaced BAEP for diagnosis.
  • BAEP still useful for screening and intraoperative monitoring.

Multiple Sclerosis

  • Brainstem involvement common in MS.
  • Prolonged III–V intervals or absent later waves.
  • Useful for demonstrating brainstem dysfunction in patients without clear clinical signs.
  • Supports dissemination in space for diagnosis.

Coma Prognostication

  • BAEPs are very resistant to anesthetic and metabolic effects.
  • Preserved BAEPs in comatose patient: brainstem function preserved.
  • Absent waves II–V in comatose patient: severe brainstem damage; poor prognosis.
  • Use with SSEP and clinical exam for multimodal prognostication.

Brain Death Determination (Ancillary)

  • In severe brain death, BAEPs may show only wave I (peripheral).
  • Loss of all waves including I: peripheral hearing loss or severe BAEP failure (may be technical).
  • Not a standalone test for brain death.

Pediatric Hearing Screening

  • Universal newborn hearing screening uses ABR (automated).
  • Sensitivity for hearing loss: ~95%.
  • Identifies severe hearing loss in newborns.

Intraoperative Monitoring

  • Used during posterior fossa surgery (acoustic neuroma resection, microvascular decompression).
  • Real-time BAEP monitoring to detect cochlear nerve injury.
  • Loss of wave V amplitude or marked latency increase triggers surgeon attention.

Brainstem Stroke

  • Lateral pontine stroke: variable BAEP changes.
  • Diagnosis primarily by MRI; BAEP confirms brainstem dysfunction.

Hereditary Spastic Paraplegia and Other Neurodegenerative Diseases

  • Some forms show abnormal BAEPs.
  • Used in specific contexts.

Pediatric BAEPs

  • Maturation: latencies shorten with age.
  • Term newborn: wave V at ~6.5 ms; adult value reached by ~2 years.
  • Used in NICU for brainstem function assessment.
  • Pediatric audiologists routinely use ABR for hearing screening.

BAEP in Anesthesia

  • Resistant to most anesthetic agents (unlike SSEPs and cortical EPs).
  • Useful for monitoring during procedures involving general anesthesia.
  • Inhalational anesthetics affect wave amplitudes slightly but latencies less.

Hearing Loss Effects on BAEP

  • Sensorineural hearing loss: variable; severe loss may absent wave I.
  • Conductive hearing loss: all waves shifted later proportionally; interpeak intervals preserved.
  • Important to characterize hearing status before BAEP interpretation.

Technical Considerations

Click vs Tone-Burst Stimulus

  • Standard click: broadband; best for clinical use.
  • Tone-burst: frequency-specific; useful for audiometric assessment.

Stimulus Intensity

  • Standard: 75 dB nHL.
  • Higher intensity activates more cochlear nerve fibers.
  • Threshold measurement requires intensity series.

Repetition Rate

  • 10–20 Hz standard.
  • Higher rates (≥50 Hz) prolong latencies (used in specific protocols).

Filter Settings

  • 100 Hz low-frequency, 3 kHz high-frequency.
  • Different settings affect wave morphology — standardize within lab.

Averaging

  • 2000–4000 stimuli typical.
  • Noise reduction proportional to √N.
  • Multiple averages of 1000-2000 stimuli often used for reliability assessment.

Reporting

A BAEP report should include:

  • Indication.
  • Stimulus parameters (intensity, rate, ear tested).
  • Wave I, III, V latencies.
  • Interpeak intervals (I–III, III–V, I–V).
  • Interaural comparison.
  • Amplitudes (less reliable but reported).
  • Comparison to lab norms.
  • Interpretation.

🔍 Did You Know?

The remarkable resistance of BAEPs to most anesthetic agents and metabolic disturbances makes them uniquely valuable for assessing brainstem function in critically ill patients. While SSEPs and cortical EPs are affected by sedation, hypothermia, and metabolic encephalopathy — making interpretation in the ICU challenging — BAEPs are largely independent of these factors. This is because the BAEP generators are subcortical (cochlear nucleus, superior olivary complex, lateral lemniscus, inferior colliculus) and operate at a level relatively unaffected by metabolic state. The clinical implications: BAEPs can confirm brainstem function in comatose patients even under heavy sedation, which has both prognostic value and use in confirming brain death. After cardiac arrest, preserved BAEPs (especially intact wave V) supports retained brainstem function and is a favorable prognostic sign in the multimodal assessment. Conversely, loss of waves II–V in a patient with intact wave I (peripheral hearing preserved) indicates severe brainstem damage and is a strong predictor of poor outcome. For practicing neurologists and intensivists, the practical implication is that BAEP can serve as a reliable test of brainstem integrity when other modalities are unreliable. The same principle generalizes to intraoperative monitoring, where BAEPs are routinely used to monitor brainstem function during surgical procedures under general anesthesia. The lesson is that different evoked potentials have different physiologic robustness, and choosing the right test for each clinical scenario is part of expert electrodiagnosis.

Pitfalls and Pearls

  • BAEP waves I–V most clinically important: cochlear nerve through mesencephalon.
  • Wave I: cochlear nerve; reflects peripheral function.
  • Wave III: superior olivary complex (pons).
  • Wave V: inferior colliculus (most prominent).
  • I–III interval: cochlear nerve to pons; classic prolongation in acoustic neuroma.
  • III–V interval: mid-pontine to mesencephalic; MS, brainstem stroke.
  • I–V interval: overall conduction; non-specific.
  • Interaural difference >0.3 ms: usually pathologic.
  • Acoustic neuroma: prolonged I–III; MRI now first test.
  • MS: brainstem dysfunction confirmation.
  • Coma prognostication: preserved BAEP = preserved brainstem function.
  • Cardiac arrest: absent waves II–V = poor prognosis.
  • Pediatric hearing screening: automated ABR standard.
  • Anesthesia-resistant: useful in OR and ICU.
  • Hearing loss: characterize before BAEP interpretation.
  • Standard click 75 dB nHL: 10–20 Hz repetition rate.
  • Average 2000–4000 stimuli: BAEP very small response.
  • Resistance to metabolic and pharmacologic effects: uniquely valuable in unstable patients.

References

  1. Hall JW III. Handbook of Auditory Evoked Responses. Allyn and Bacon; 1992.
  2. Mauguière F, Allison T, Babiloni C, et al. Brainstem auditory evoked potentials. Recommendations for the Practice of Clinical Neurophysiology: Guidelines of the IFCN. 2nd ed. Elsevier; 1999:55-65.
  3. Chiappa KH. Evoked Potentials in Clinical Medicine. 3rd ed. Lippincott-Raven; 1997.
  4. Aminoff MJ, ed. Aminoff’s Electrodiagnosis in Clinical Neurology. 6th ed. Elsevier; 2012.
  5. Walsh P, Kane N, Butler S. The clinical role of evoked potentials. J Neurol Neurosurg Psychiatry. 2005;76(suppl 2):ii16-ii22.